Molecular mechanism underlying lymphatic metastasis in pancreatic cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Xiao, Zhiwen ^a,b   Luo, Guopei ^a,b   Liu, Chen ^a,b   Wu, Chuntao ^a,b   Liu, Liang ^a,b   Liu, Zuqiang ^a,b   Ni, Quanxing ^a,b   Long, Jiang ^b   Yu, Xianjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; TUMOR RECURRENCE;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893775011     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/925845     Document Type: Review

References (130)

1. Vincent A., Herman J., Schulick R., Hruban R. H., Goggins M., Pancreatic cancer. The Lancet 2011 378 9791 607 620 2-s2.0-80051700067 10.1016/S0140- 6736(10)62307-0
2. Slidell M. B., Chang D. C., Cameron J. L., Wolfgang C., Herman J. M., Schulick R. D., Choti M. A., Pawlik T. M., Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Annals of Surgical Oncology 2008 15 1 165 174 2-s2.0-38049103003 10.1245/s10434-007-9587-1
3. Furukawa H., Okada S., Saisho H., Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer 1996 78 986 990 (Pubitemid 26284862)
4. Hosch S. B., Knoefel W. T., Metz S., Stoecklein N., Niendorf A., Broelsch C. E., Izbicki J. R., Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997 15 2 154 159 2-s2.0-0030735190 (Pubitemid 27524691)
5. Demeure M. J., Doffek K. M., Komorowski R. A., Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer 1998 83 1328 1334 (Pubitemid 28460083)
6. Ando N., Nakao A., Nomoto S., Takeda S., Kaneko T., Kurokawa T., Nonami T., Takagi H., Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Pancreas 1997 15 4 374 378 2-s2.0-0030780232 (Pubitemid 27525633)
7. Achen M. G., Stacker S. A., Molecular control of lymphatic metastasis. Annals of the New York Academy of Sciences 2008 1131 225 234 2-s2.0-44449133602 10.1196/annals.1413.020 (Pubitemid 351758517)
8. Rosen J. M., Jordan C. T., The increasing complexity of the cancer stem cell paradigm. Science 2009 324 5935 1670 1673 2-s2.0-67649939163 10.1126/science.1171837
9. Hermann P. C., Huber S. L., Herrler T., Aicher A., Ellwart J. W., Guba M., Bruns C. J., Heeschen C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007 1 3 313 323 2-s2.0-34548455927 10.1016/j.stem.2007.06.002 (Pubitemid 47355323)
10. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T., Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Reviews Cancer 2005 5 9 744 749 2-s2.0-25444495269 10.1038/nrc1694 (Pubitemid 41486367)
11. Ni X., Long J., Cen P., Pancreatic cancer tumor initiating cells: the molecular regulation and therapeutic values. Journal of Cellular and Molecular Medicine 2011 16 5 988 994
12. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997 3 7 730 737 2-s2.0-0030789242 10.1038/nm0797-730 (Pubitemid 27298715)
13. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
14. Maeda S., Shinchi H., Kurahara H., Mataki Y., Maemura K., Sato M., Natsugoe S., Aikou T., Takao S., CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. British Journal of Cancer 2008 98 8 1389 1397 2-s2.0-42149158769 10.1038/sj.bjc.6604307 (Pubitemid 351543575)
15. Ishizawa K., Rasheed Z. A., Karisch R., Wang Q., Kowalski J., Susky E., Pereira K., Karamboulas C., Moghal N., Rajeshkumar N. V., Hidalgo M., Tsao M., Ailles L., Waddell T. K., Maitra A., Neel B. G., Matsui W., Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 2010 7 3 279 282 2-s2.0-77956214387 10.1016/j.stem.2010.08.009
16. Cui K., Zhao W., Wang C., Wang A., Zhang B., Zhou W., Yu J., Sun Z., Li S., The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. Journal of Surgical Research 2011 171 1 143 150 2-s2.0-80054697462 10.1016/j.jss.2010.03.001
17. Singh S., Srivastava S. K., Bhardwaj A., Owen L. B., Singh A. P., CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. British Journal of Cancer 2010 103 11 1671 1679 2-s2.0-78650194206 10.1038/sj.bjc.6605968
18. Li R., Sonik A., Stindl R., Rasnick D., Duesberg P., Aneuploidy versus gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3236 3241 2-s2.0-0034724312 10.1073/pnas.040529797 (Pubitemid 30183285)
19. Wu C., Miao X., Huang L., Che X., Jiang G., Yu D., Yang X., Cao G., Hu Z., Zhou Y., Zuo C., Wang C., Zhang X., Zhou Y., Yu X., Dai W., Li Z., Shen H., Liu L., Chen Y., Zhang S., Wang X., Zhai K., Chang J., Liu Y., Sun M., Cao W., Gao J., Ma Y., Zheng X., Cheung S. T., Jia Y., Xu J., Tan W., Zhao P., Wu T., Wang C., Lin D., Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nature Genetics 2012 44 1 62 66 2-s2.0-84655162046 10.1038/ng.1020
20. Long J., Luo G., Liu C., Development of a unique mouse model for pancreatic cancer lymphatic metastasis. International Journal of Oncology 2012 41 1662 1668
21. Aguirre A. J., Bardeesy N., Sinha M., Lopez L., Tuveson D. A., Horner J., Redston M. S., DePinho R. A., Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes and Development 2003 17 24 3112 3126 2-s2.0-0346455774 10.1101/gad.1158703 (Pubitemid 38040774)
22. Hingorani S. R., Wang L., Multani A. S., Combs C., Deramaudt T. B., Hruban R. H., Rustgi A. K., Chang S., Tuveson D. A., Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005 7 5 469 483 2-s2.0-19344362405 10.1016/j.ccr.2005.04.023 (Pubitemid 40719130)
23. Morton J. P., Timpson P., Karim S. A., Ridgway R. A., Athineos D., Doyle B., Jamieson N. B., Oien K. A., Lowy A. M., Brunton V. G., Frame M. C., Evans T. R. J., Sansom O. J., Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 2010 107 1 246 251 2-s2.0-76249108357 10.1073/pnas.0908428107
24. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., Kamiyama M., Hruban R. H., Eshleman J. R., Nowak M. A., Velculescu V. E., Kinzler K. W., Vogelstein B., Iacobuzio-Donahue C. A., Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010 467 7319 1114 1117 2-s2.0-78049398107 10.1038/nature09515
25. Campbell P. J., Yachida S., Mudie L. J., Stephens P. J., Pleasance E. D., Stebbings L. A., Morsberger L. A., Latimer C., McLaren S., Lin M.-L., McBride D. J., Varela I., Nik-Zainal S. A., Leroy C., Jia M., Menzies A., Butler A. P., Teague J. W., Griffin C. A., Burton J., Swerdlow H., Quail M. A., Stratton M. R., Iacobuzio-Donahue C., Futreal P. A., The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010 467 7319 1109 1113 2-s2.0-78049380554 10.1038/nature09460
26. Kim H. N., Choi D. W., Lee K. T., Lee J. K., Heo J. S., Choi S.-H., Paik S. W., Rhee J. C., Lowe A. W., Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer. Pancreas 2007 34 3 325 334 2-s2.0-34247154370 10.1097/MPA.0b013e3180317b01 (Pubitemid 46588258)
27. Nakamura T., Furukawa Y., Nakagawa H., Tsunoda T., Ohigashi H., Murata K., Ishikawa O., Ohgaki K., Kashimura N., Miyamoto M., Hirano S., Kondo S., Katoh H., Nakamura Y., Katagiri T., Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004 23 13 2385 2400 2-s2.0-1842484829 10.1038/sj.onc.1207392 (Pubitemid 38496794)
28. Visus C., Wang Y., Lozano-Leon A., Ferris R. L., Silver S., Szczepanski M. J., Brand R. E., Ferrone C. R., Whiteside T. L., Ferrone S., DeLeo A. B., Wang X., Targeting ALDHbright human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells. Clinical Cancer Research 2011 17 19 6174 6184 2-s2.0-80053542413 10.1158/1078-0432.CCR-11-1111
29. Hamada S., Masamune A., Takikawa T., Suzuki N., Kikuta K., Hirota M., Hamada H., Kobune M., Satoh K., Shimosegawa T., Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochemical and Biophysical Research Communications 2012 421 2 349 354 2-s2.0-84860431671 10.1016/j.bbrc.2012.04.014
30. Wang F., Xue X., Wei J., An Y., Yao J., Cai H., Wu J., Dai C., Qian Z., Xu Z., Miao Y., Hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. British Journal of Cancer 2010 103 4 567 574 2-s2.0-77955517749 10.1038/sj.bjc.6605724
31. Marchesi F., Monti P., Leone B. E., Zerbi A., Vecchi A., Piemonti L., Mantovani A., Allavena P., Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Research 2004 64 22 8420 8427 2-s2.0-8544223594 10.1158/0008-5472.CAN-04-1343 (Pubitemid 39491782)
32. Calin G. A., Croce C. M., MicroRNA signatures in human cancers. Nature Reviews Cancer 2006 6 11 857 866 2-s2.0-33750370444 10.1038/nrc1997 (Pubitemid 44629897)
33. Tavano F., di Mola F. F., Piepoli A., Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas 2012 41 1280 1284
34. Kent O. A., Chivukula R. R., Mullendore M., Wentzel E. A., Feldmann G., Lee K. H., Liu S., Leach S. D., Maitra A., Mendell J. T., Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes and Development 2010 24 24 2754 2759 2-s2.0-78650204499 10.1101/gad.1950610
35. Yu S., Lu Z., Liu C., Meng Y., Ma Y., Zhao W., Liu J., Yu J., Chen J., miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Research 2010 70 14 6015 6025 2-s2.0-77955033963 10.1158/0008-5472.CAN-09-4531
36. Srivastava S. K., Bhardwaj A., Singh S., Arora S., Wang B., Grizzle W. E., Singh A. P., MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 2011 32 12 1832 1839 2-s2.0-81855183857 10.1093/carcin/bgr223
37. Choudhury A., Moniaux N., Ulrich A. B., Schmied B. M., Standop J., Pour P. M., Gendler S. J., Hollingsworth M. A., Aubert J.-P., Batra S. K., MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGF β 2. British Journal of Cancer 2004 90 3 657 664 2-s2.0-10744220442 10.1038/sj.bjc.6601604 (Pubitemid 38297207)
38. Wellner U., Schubert J., Burk U. C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V. G., Morton J., Sansom O., Schüler J., Stemmler M. P., Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T., The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biology 2009 11 12 1487 1495 2-s2.0-73049110243
39. Ji Q., Hao X., Zhang M., Tang W., Meng Y., Li L., Xiang D., DeSano J. T., Bommer G. T., Fan D., Fearon E. R., Lawrence T. S., Xu L., MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 2009 4 8 2-s2.0-69949087531 10.1371/journal.pone.0006816 e6816
40. Ohuchida K., Mizumoto K., Lin C., Yamaguchi H., Ohtsuka T., Sato N., Toma H., Nakamura M., Nagai E., Hashizume M., Tanaka M., MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Annals of Surgical Oncology 2012 19 2394 2402 2-s2.0-84857871152 10.1245/s10434-012-2252-3
41. Weiss F. U., Marques I. J., Woltering J. M., Vlecken D. H., Aghdassi A., Partecke L. I., Heidecke C.-D., Lerch M. M., Bagowski C. P., Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009 137 6 2136 2145 2-s2.0-70649104670 10.1053/j.gastro.2009.08.065
42. Ma Y., Yu S., Zhao W., Lu Z., Chen J., MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Letters 2010 298 2 150 158 2-s2.0-77957948990 10.1016/j.canlet.2010.06. 012
43. Drabsch Y., Ten D. P., TGF-beta signalling and its role in cancer progression and metastasis. Cancer and Metastasis Reviews 2012 31 553 568
44. Wang P., Fan J., Chen Z., Meng Z.-Q., Luo J.-M., Lin J.-H., Zhou Z.-H., Chen H., Wang K., Xu Z.-D., Liu L.-M., Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer. Annals of Surgical Oncology 2009 16 4 826 835 2-s2.0-62149136344 10.1245/s10434-008-0284-5
45. Jiang H., He C., Geng S., RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer. PLoS ONE 2012 7 e42234
46. Kabashima A., Higuchi H., Takaishi H., Matsuzaki Y., Suzuki S., Izumiya M., Iizuka H., Sakai G., Hozawa S., Azuma T., Hibi T., Side population of pancreatic cancer cells predominates in TGF- β -mediated epithelial to mesenchymal transition and invasion. International Journal of Cancer 2009 124 12 2771 2779 2-s2.0-65649095142 10.1002/ijc.24349
47. Hosotani R., Kawaguchi M., Masui T., Koshiba T., Ida J., Fujimoto K., Wada M., Doi R., Imamura M., Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas 2002 25 2 e30 e35 2-s2.0-18844469913
48. Desgrosellier J. S., Barnes L. A., Shields D. J., Huang M., Lau S. K., Prévost N., Tarin D., Shattil S. J., Cheresh D. A., An integrin α v Β 3-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nature Medicine 2009 15 10 1163 1169 2-s2.0-70350574674 10.1038/nm.2009
49. Dai J., Ai K., Du Y., Chen G., Sonic hedgehog expression correlates with distant metastasis in pancreatic adenocarcinoma. Pancreas 2011 40 2 233 236 2-s2.0-79951723434 10.1097/MPA.0b013e3181f7e09f
50. Eberl M., Klingler S., Mangelberger D., Loipetzberger A., Damhofer H., Zoidl K., Schnidar H., Hache H., Bauer H.-C., Solca F., Hauser-Kronberger C., Ermilov A. N., Verhaegen M. E., Bichakjian C. K., Dlugosz A. A., Nietfeld W., Sibilia M., Lehrach H., Wierling C., Aberger F., Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Molecular Medicine 2012 4 3 218 233 2-s2.0-84858142098 10.1002/emmm.201100201
51. Joost S., Almada L. L., Rohnalter V., Holz P. S., Vrabel A. M., Fernandez-Barrena M. G., McWilliams R. R., Krause M., Fernandez-Zapico M. E., Lauth M., GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Research 2012 72 1 88 99 2-s2.0-84855391207 10.1158/0008-5472.CAN-10-4621
52. Bailey J. M., Swanson B. J., Hamada T., Eggers J. P., Singh P. K., Caffery T., Ouellette M. M., Hollingsworth M. A., Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clinical Cancer Research 2008 14 19 5995 6004 2-s2.0-58149143021 10.1158/1078-0432.CCR-08-0291
53. Lai E. C., Notch signaling: control of cell communication and cell fate. Development 2004 131 5 965 973 2-s2.0-1642382833 10.1242/dev.01074 (Pubitemid 38380451)
54. Mullendore M. E., Koorstra J.-B., Li Y.-M., Offerhaus G. J., Fan X., Henderson C. M., Matsui W., Eberhart C. G., Maitra A., Feldmann G., Ligand-dependent notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clinical Cancer Research 2009 15 7 2291 2301 2-s2.0-65249147725 10.1158/1078-0432.CCR-08-2004
55. Chen H.-T., Cai Q.-C., Zheng J.-M., Man X.-H., Jiang H., Song B., Jin G., Zhu W., Li Z.-S., High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Annals of Surgical Oncology 2012 464 474 2-s2.0-79961108094 10.1245/s10434-011-1968-9
56. Bao B., Wang Z., Ali S., Kong D., Li Y., Ahmad A., Banerjee S., Azmi A. S., Miele L., Sarkar F. H., Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters 2011 307 1 26 36 2-s2.0-79957487931 10.1016/j.canlet.2011.03.012
57. Sureban S. M., May R., Lightfoot S. A., Hoskins A. B., Lerner M., Brackett D. J., Postier R. G., Ramanujam R., Mohammed A., Rao C. V., Wyche J. H., Anant S., Houchen C. W., DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Research 2011 71 6 2328 2338 2-s2.0-79952748822 10.1158/0008-5472.CAN-10- 2738
58. Hanlon L., Avila J. L., Demarest R. M., Troutman S., Allen M., Ratti F., Rustgi A. K., Stanger B. Z., Radtke F., Adsay V., Long F., Capobianco A. J., Kissil J. L., Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Research 2010 70 11 4280 4286 2-s2.0-77953158971 10.1158/0008-5472.CAN-09-4645
59. De La O J.-P., Emerson L. L., Goodman J. L., Froebe S. C., Illum B. E., Curtis A. B., Murtaugh L. C., Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proceedings of the National Academy of Sciences of the United States of America 2008 105 48 18907 18912 2-s2.0-57749116315 10.1073/pnas.0810111105
60. De La O J.-P., Murtaugh L. C., Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling. Cell Cycle 2009 8 12 1860 1864 2-s2.0-67649313759
61. Li Y., VandenBoom T. G. II, Wang Z., Kong D., Ali S., Philip P. A., Sarkar F. H., miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research 2010 70 4 1486 1495 2-s2.0-76749152907 10.1158/0008-5472.CAN-09-2792
62. Dangi-Garimella S., Strouch M. J., Grippo P. J., Bentrem D. J., Munshi H. G., Collagen regulation of let-7 in pancreatic cancer involves TGF- β 1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 2011 30 8 1002 1008 2-s2.0-79952005676 10.1038/onc.2010.485
63. Yan H., Wu J., Liu W., Zuo Y., Chen S., Zhang S., Zeng M., Huang W., MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Human Gene Therapy 2010 21 12 1723 1734 2-s2.0-78650096337 10.1089/hum.2010.061
64. Hamada S., Satoh K., Fujibuchi W., Hirota M., Kanno A., Unno J., Masamune A., Kikuta K., Kume K., Shimosegawa T., MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Molecular Cancer Research 2012 10 1 3 10 2-s2.0-84855992618 10.1158/1541-7786.MCR-11-0272
65. Joglekar M. V., Patil D., Joglekar V. M., Rao G. V., Reddy D. N., Mitnala S., Shouche Y., Hardikar A. A., The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 2009 1 2 137 147 2-s2.0-79951705428
66. Mees S. T., Mardin W. A., Sielker S., Willscher E., Senninger N., Schleicher C., Colombo-Benkmann M., Haier J., Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Annals of Surgical Oncology 2009 16 8 2339 2350 2-s2.0-67650999145 10.1245/s10434-009-0531-4
67. Li X., Ma Q., Xu Q., Liu H., Lei J., Duan W., Bhat K., Wang F., Wu E., Wang Z., SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Letters 2012 322 169 176 2-s2.0-84859805390 10.1016/j.canlet.2012.02.035
68. Mimeault M., Batra S. K., Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut 2008 57 10 1456 1468 2-s2.0-52649091291 10.1136/gut.2008.150052
69. Wang Z., Ma Q., Liu Q., Yu H., Zhao L., Shen S., Yao J., Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. British Journal of Cancer 2008 99 10 1695 1703 2-s2.0-55949116428 10.1038/sj.bjc.6604745
70. Thomas R. M., Kim J., Revelo-Penafiel M. P., Angel R., Dawson D. W., Lowy A. M., The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia. Gut 2008 57 11 1555 1560 2-s2.0-54349112926 10.1136/gut.2007.143941
71. Saur D., Seidler B., Schneider G., Algül H., Beck R., Senekowitsch-Schmidtke R., Schwaiger M., Schmid R. M., CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 2005 129 4 1237 1250 2-s2.0-26844527356 10.1053/j.gastro.2005. 06.056 (Pubitemid 41446863)
72. Liu F., Lang R., Wei J., Fan Y., Cui L., Gu F., Guo X., Pringle G. A., Zhang X., Fu L., Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology 2009 54 6 741 750 2-s2.0-65349158225 10.1111/j.1365-2559.2009. 03289.x
73. Chang S.-C., Lin P.-C., Yang S.-H., Wang H.-S., Li A. F.-Y., Lin J.-K., SDF-1 α G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Annals of Surgical Oncology 2009 16 8 2323 2330 2-s2.0-67650998818 10.1245/s10434-009-0501-x
74. Zhao B.-C., Wang Z.-J., Mao W.-Z., Ma H.-C., Han J.-G., Zhao B., Xu H.-M., CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World Journal of Gastroenterology 2011 17 19 2389 2396 2-s2.0-79957842997 10.3748/wjg.v17.i19.2389
75. Shen X., Artinyan A., Jackson D., Thomas R. M., Lowy A. M., Kim J., Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through akt and erk dependent pathways. Pancreas 2010 39 1 81 87 2-s2.0-74049098310 10.1097/MPA.0b013e3181bb2ab7
76. Lee Y., Kim S. J., Park H. D., Park E. H., Huang S. M., Jeon S. B., Kim J.-M., Lim D.-S., Koh S. S., PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression. Oncogene 2010 29 1 56 67 2-s2.0-73849145679 10.1038/onc.2009.298
77. Lee Y., Kim S. J., Min H. J., Jo J. Y., Park E. H., Koh S. S., PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase. Experimental and Molecular Medicine 2011 43 5 291 297 2-s2.0-79958833779 10.3858/emm.2011.43.5.030
78. Chen Z., Chen L. Y., Wang P., Tumor microenvironment varies under different TCM ZHENG models and correlates with treatment response to herbal medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 635702 10.1155/2012/635702
79. Mori T., Doi R., Koizumi M., Toyoda E., Ito D., Kami K., Masui T., Fujimoto K., Tamamura H., Hiramatsu K., Fuji N., Imamura M., CXCR4 antagonist inhibits stromall cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Molecular Cancer Therapeutics 2004 3 1 29 37 2-s2.0-2942692286 (Pubitemid 39193676)
80. Issa A., Le T. X., Shoushtari A. N., Shields J. D., Swartz M. A., Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Research 2009 69 1 349 357 2-s2.0-58249124355 10.1158/0008-5472.CAN-08-1875
81. Sperveslage J., Frank S., Heneweer C., Egberts J., Schniewind B., Buchholz M., Bergmann F., Giese N., Munding J., Hahn S. A., Kalthoff H., Klöppel G., Sipos B., Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. International Journal of Cancer 2012 131 E371 E381 2-s2.0-84855587159 10.1002/ijc.26502
82. Shields J. D., Fleury M. E., Yong C., Tomei A. A., Randolph G. J., Swartz M. A., Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 2007 11 6 526 538 2-s2.0-34249774277 10.1016/j.ccr.2007.04.020 (Pubitemid 46856909)
83. Emmett M. S., Lanati S., Dunn D. B. A., Stone O. A., Bates D. O., CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation 2011 18 3 172 182 2-s2.0-79953020878 10.1111/j.1549-8719.2010.00074.x
84. Kurahara H., Takao S., Maemura K., Shinchi H., Natsugoe S., Aikou T., Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clinical Cancer Research 2004 10 24 8413 8420 2-s2.0-11144234518 10.1158/1078-0432.CCR-04-0379 (Pubitemid 40053404)
85. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., Alitalo K., Proteolytic processing regulates receptor specificity and activity of VEGF-C. The EMBO Journal 1997 16 13 3898 3911 2-s2.0-0031011529 10.1093/emboj/16.13.3898 (Pubitemid 27281006)
86. Stacker S. A., Stenvers K., Caesar C., Vitali A., Domagala T., Nice E., Roufail S., Simpson R. J., Moritz R., Karpanen T., Alitalo K., Achen M. G., Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. Journal of Biological Chemistry 1999 274 45 32127 32136 2-s2.0-0033527634 10.1074/jbc.274.45.32127 (Pubitemid 29522952)
87. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., Alitalo K., Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Research 2005 65 11 4739 4746 2-s2.0-21144437844 10.1158/0008-5472.CAN-04-4576 (Pubitemid 40740810)
88. Smith N. R., Baker D., James N. H., Ratcliffe K., Jenkins M., Ashton S. E., Sproat G., Swann R., Gray N., Ryan A., Jürgensmeier J. M., Womack C., Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clinical Cancer Research 2010 16 14 3548 3561 2-s2.0-77954722597 10.1158/1078-0432.CCR-09-2797
89. Kaplan R. N., Psaila B., Lyden D., Bone marrow cells in the "pre-metastatic niche": within bone and beyond. Cancer and Metastasis Reviews 2006 25 4 521 529 2-s2.0-33846044750 10.1007/s10555-006-9036-9 (Pubitemid 46071861)
90. Tang R. F., Itakura J., Aikawa T., Matsuda K., Fujii H., Korc M., Matsumoto Y., Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 2001 22 3 285 292 2-s2.0-0035086990 10.1097/00006676-200104000-00010 (Pubitemid 32242495)
91. Alitalo K., Carmeliet P., Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002 1 3 219 227 2-s2.0-0036527585 10.1016/S1535-6108(02)00051-X (Pubitemid 41039145)
92. Schneider M., Büchler P., Giese N., Giese T., Wilting J., Büchler M. W., Friess H., Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. International Journal of Oncology 2006 28 4 883 890 2-s2.0-33744757680
93. Cao R., Björndahl M. A., Religa P., Clasper S., Garvin S., Galter D., Meister B., Ikomi F., Tritsaris K., Dissing S., Ohhashi T., Jackson D. G., Cao Y., PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004 6 333 345 (Pubitemid 39361435)
94. Lee K., Park D. J., Choe G., Kim H. H., Kim W. H., Lee H. S., Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Annals of Surgical Oncology 2010 17 1 73 80 2-s2.0-74649086696 10.1245/s10434-009-0707-y
95. Otto N., Schulz P., Scholz A., Hauff P., Schlegelberger B., Detjen K. M., Wiedenmann B., The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. British Journal of Cancer 2012 106 2 348 357 2-s2.0-84856491650 10.1038/bjc.2011.521
96. Nakata B., Fukunaga S., Noda E., Amano R., Yamada N., Hirakawa K., Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 2008 74 1-2 69 75 2-s2.0-46249101229 10.1159/000139126 (Pubitemid 351915012)
97. Wuest T. R., Carr D. J. J., VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. Journal of Experimental Medicine 2010 207 1 101 115 2-s2.0-76149123190 10.1084/jem.20091385
98. Saito Y., Nakagami H., Morishita R., Takami Y., Kikuchi Y., Hayashi H., Nishikawa T., Tamai K., Azuma N., Sasajima T., Kaneda Y., Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006 114 11 1177 1184 2-s2.0-33748670727 10.1161/CIRCULATIONAHA.105.602953 (Pubitemid 44386482)
99. Tang R.-F., Wang S.-X., Peng L., Wang S.-X., Zhang M., Li Z.-F., Zhang Z.-M., Xiao Y., Zhang F.-R., Expression of vascular endothelial growth factors A and C in human pancreatic cancer. World Journal of Gastroenterology 2006 12 2 280 286 2-s2.0-33644779111 (Pubitemid 43336928)
100. Luo G., Long J., Zhang B., Liu C., Xu J., Ni Q., Yu X., Stroma and pancreatic ductal adenocarcinoma: an interaction loop. Biochimica et Biophysica Acta 2012 1826 1 170 178 2-s2.0-84860281544 10.1016/j.bbcan.2012.04.002
101. Hussain F., Wang J., Ahmed R., Guest S. K., Lam E. W.-F., Stamp G., El-Bahrawy M., The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours. Cytokine 2010 49 2 134 140 2-s2.0-73649093726 10.1016/j.cyto.2009.11.010
102. Brentnall T. A., Lai L. A., Coleman J., Bronner M. P., Pan S., Chen R., Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS ONE 2012 7 1 2-s2.0-84856092772 10.1371/journal.pone.0030219 e30219
103. Algül H., Treiber M., Lesina M., Schmid R. M., Mechanisms of disease: chronic inflammation and cancer in the pancreas-a potential role for pancreatic stellate cells? Nature Clinical Practice Gastroenterology and Hepatology 2007 4 8 454 462 2-s2.0-34547652547 10.1038/ncpgasthep0881 (Pubitemid 47208895)
104. Jung T., Castellana D., Klingbeil P., Hernández I. C., Vitacolonna M., Orlicky D. J., Roffler S. R., Brodt P., Zöller M., CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009 11 10 1093 1105 2-s2.0-70149123439 10.1593/neo.09822
105. He Y., Liu X.-D., Chen Z.-Y., Zhu J., Xiong Y., Li K., Dong J.-H., Li X., Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clinical Cancer Research 2007 13 11 3115 3124 2-s2.0-34250685355 10.1158/1078-0432.CCR-06-2088 (Pubitemid 46944892)
106. Yamato I., Sho M., Nomi T., Akahori T., Shimada K., Hotta K., Kanehiro H., Konishi N., Yagita H., Nakajima Y., Clinical importance of B7-H3 expression in human pancreatic cancer. British Journal of Cancer 2009 101 10 1709 1716 2-s2.0-70449534753 10.1038/sj.bjc.6605375
107. DeNardo D. G., Barreto J. B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L. M., CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009 16 2 91 102 2-s2.0-67651160649 10.1016/j.ccr.2009.06.018
108. Qian B.-Z., Pollard J. W., Macrophage diversity enhances tumor progression and metastasis. Cell 2010 141 1 39 51 2-s2.0-77950950894 10.1016/j.cell.2010.03.014
109. Li N., Grivennikov S. I., Karin M., The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011 19 4 429 431 2-s2.0-79953749145 10.1016/j.ccr.2011.03.018
110. Kaplan R. N., Riba R. D., Zacharoulis S., Bramley A. H., Vincent L., Costa C., MacDonald D. D., Jin D. K., Shido K., Kerns S. A., Zhu Z., Hicklin D., Wu Y., Port J. L., Altorki N., Port E. R., Ruggero D., Shmelkov S. V., Jensen K. K., Rafii S., Lyden D., VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005 438 7069 820 827 2-s2.0-28644432204 10.1038/nature04186 (Pubitemid 41753060)
111. Erler J. T., Bennewith K. L., Nicolau M., Dornhöfer N., Kong C., Le Q.-T., Chi J.-T. A., Jeffrey S. S., Giaccia A. J., Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006 440 7088 1222 1226 2-s2.0-33646365644 10.1038/nature04695
112. Erler J. T., Bennewith K. L., Cox T. R., Lang G., Bird D., Koong A., Le Q.-T., Giaccia A. J., Macrophage diversity enhances tumor progression and metastasis. Cancer Cell 2009 15 1 35 44 2-s2.0-57849100048 10.1016/j.ccr.2008. 11.012
113. Hiratsuka S., Watanabe A., Aburatani H., Maru Y., Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biology 2006 8 12 1369 1375 2-s2.0-33751504690 10.1038/ncb1507 (Pubitemid 44835111)
114. Peinado H., Aleckovic M., Lavotshkin S., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine 2012 18 883 891
115. Hayashi K., Zhao M., Yamauchi K., Yamamoto N., Tsuchiya H., Tomita K., Hoffman R. M., Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. Journal of Cellular Biochemistry 2009 106 6 992 998 2-s2.0-66149147856 10.1002/jcb.22078
116. Luo G., Yu X., Jin C., Yang F., Fu D., Long J., Xu J., Zhan C., Lu W., LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. International Journal of Pharmaceutics 2010 385 1-2 150 156 2-s2.0-72149086003 10.1016/j.ijpharm.2009.10.014
117. Zhao S., Venkatasubbarao K., Lazor J. W., Sperry J., Jin C., Cao L., Freeman J. W., Inhibition of STAT3Tyr705 phosphorylation by Smad4 suppresses transforming growth factor β -mediated invasion and metastasis in pancreatic cancer cells. Cancer Research 2008 68 11 4221 4228 2-s2.0-49249095430 10.1158/0008-5472.CAN-07-5123
118. Spano J.-P., Chodkiewicz C., Maurel J., Wong R., Wasan H., Barone C., Létourneau R., Bajetta E., Pithavala Y., Bycott P., Trask P., Liau K., Ricart A. D., Kim S., Rixe O., Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study. The Lancet 2008 371 9630 2101 2108 2-s2.0-45449090215 10.1016/S0140-6736(08)60661-3
119. Kindler H. L., Ioka T., Richel D. J., Bennouna J., Létourneau R., Okusaka T., Funakoshi A., Furuse J., Park Y. S., Ohkawa S., Springett G. M., Wasan H. S., Trask P. C., Bycott P., Ricart A. D., Kim S., van Cutsem E., Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. The Lancet Oncology 2011 12 3 256 262 2-s2.0-79952036599 10.1016/S1470-2045(11) 70004-3
120. Friedmann T., Roblin R., Gene therapy for human genetic disease? Science 1972 175 4025 949 955 2-s2.0-0015492624
121. Blaese R. M., Culver K. W., Miller A. D., Carter C. S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., Greenblatt J. J., Rosenberg S. A., Klein H., Berger M., Mullen C. A., Ramsey W. J., Muul L., Morgan R. A., Anderson W. F., T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995 270 5235 475 480 2-s2.0-0028807727
122. Mukherjee S., Thrasher A. J., Progress and prospects: advancements in retroviral vector design, generation, and application. Human Gene Therapy 2011 22 10 1171 1174 2-s2.0-80155139422 10.1089/hum.2011.2523
123. Dong J. Y., Woraratanadharm J., Gene therapy vector design strategies for the treatment of cancer. Future Oncology 2005 1 3 361 373 2-s2.0-33646455930 10.1517/14796694.1.3.361
124. Kauer T. M., Figueiredo J.-L., Hingtgen S., Shah K., Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nature Neuroscience 2012 15 2 197 204 2-s2.0-84856263167 10.1038/nn.3019
125. Delouys F., Biological treatment of cancer. Le Scalpel 1953 106 43 1234 1238 2-s2.0-77951420701
126. Péron J. M., Bureau C., Gourdy P., Lulka H., Souque A., Calippe B., Selves J., Al Saati T., Bernad J., Cordelier P., Couderc B., Pradayrol L., Pipy B., Buscail L., Vinel J. P., Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity. Gut 2007 56 1 107 114 2-s2.0-33846001023 10.1136/gut.2005.083477 (Pubitemid 46044896)
127. Cioffi M., Dorado J., Baeuerle P. A., Heeschen C., EpCAM/CD3-bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells. Clinical Cancer Research 2012 18 2 465 474 2-s2.0-84856007019 10.1158/1078-0432.CCR-11-1270
128. Groth A., Salnikov A. V., Ottinger S., Gladkich J., Liu L., Kallifatidis G., Salnikova O., Ryschich E., Giese N., Giese T., Momburg F., Büchler M. W., Moldenhauer G., Herr I., New gene-immunotherapy combining TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody for tumor targeting. Clinical Cancer Research 2012 18 4 1028 1038 2-s2.0-84857072577 10.1158/1078-0432.CCR-11-2767
129. Olive K. P., Jacobetz M. A., Davidson C. J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M. A., Caldwell M. E., Allard D., Frese K. K., DeNicola G., Feig C., Combs C., Winter S. P., Ireland-Zecchini H., Reichelt S., Howat W. J., Chang A., Dhara M., Wang L., Rückert F., Grützmann R., Pilarsky C., Izeradjene K., Hingorani S. R., Huang P., Davies S. E., Plunkett W., Egorin M., Hruban R. H., Whitebread N., McGovern K., Adams J., Iacobuzio-Donahue C., Griffiths J., Tuveson D. A., Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009 324 5933 1457 1461 2-s2.0-67149143399 10.1126/science. 1171362
130. Jacobetz M. A., Chan D. S., Neesse A., Bapiro T. E., Cook N., Frese K. K., Feig C., Nakagawa T., Caldwell M. E., Zecchini H. I., Lolkema M. P., Jiang P., Kultti A., Thompson C. B., Maneval D. C., Jodrell D. I., Frost G. I., Shepard H. M., Skepper J. N., Tuveson D. A., Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2012 62 112 120 2-s2.0-84859043587 10.1136/gutjnl-2012-302529